Utilizing Personalized Analytics and Biosensors in Healthcare

June 22, 2021 PTV-06-21-CL-004

Chris Economos, Chief Commercial Officer of PhysIQ, explains how the company utilizes artificial intelligence to analyze biosensor data, and specifically highlights how the technology has the potential to impact the industry, including how drugs are developed and patients are cared for.

Chris Economos

As Chief Commercial Officer, Chris leads the physIQ commercial operation, including go-to-market strategy, marketing, sales and strategic partnerships. Chris brings an extensive background in developing, selling and implementing healthcare solutions that involve complex transactions across multiple stakeholders. Prior to joining physIQ, Chris was part of the leadership team at Healthy Interactions, the global leader in diabetes education and, before that, a marketing manager at AbbVie (formerly Abbott). Chris holds a BS from Vanderbilt University and earned his MBA at the Indiana University Kelley School of Business.

Q: